MDGS - Sorrento Therapeutics Ocular Therapeutix among major healthcare premarket losers' pack

Cyclerion Therapeutics (CYCN) -41% after Phase 2 STRONG-SCD study results in patients with Sickle Cell Disease.Sorrento Therapeutics (SRNE) -12%.Aethlon Medical (AEMD) -11%.Enzo Biochem ENZ -10% on FQ4 earnings results.Auris Medical Holding (EARS) -10%.SOS  (SOS) -10%.Ocular Therapeutix (OCUL) -8% on pricing ~$70M equity offering and agreement with FDA to conduct retrospective study for ReSure sealant.Medigus (MDGS) -7% iBio (IBIO) -6% after FY earnings results.AMC Entertainment Holdings (AMC) -6% after responding to report about bankruptcy consideration.PEDEVCO (PED) -6%.Milestone Scientific (MLSS) -5%.

For further details see:

Sorrento Therapeutics, Ocular Therapeutix among major healthcare premarket losers' pack